文献速递认知障碍与痴呆

甲状腺疾病与痴呆风险:一项全国性人群病例对照研究

Thyroid Disorders and Dementia Risk: A Nationwide Population-Based Case-Control Study.
PubMed 文献 · Neurology · 2022-07-06

该研究基于台湾地区全民健康保险研究数据库,纳入2006至2013年新诊断痴呆的7843例成人及年龄性别匹配的7843例对照。结果显示,65岁及以上人群中,有甲状腺功能减退史与痴呆诊断风险升高相关(aOR 1.81),其中需甲状腺激素替代治疗者风险更高(aOR 3.17)。

要点

  • 65岁及以上人群中,有甲状腺功能减退史与痴呆风险升高相关(aOR 1.81)。
  • 该关联在50至65岁人群中未观察到。
  • 需甲状腺激素替代治疗的甲减患者痴呆风险更高(aOR 3.17)。

核心结论

  • 在65岁及以上人群中,有甲状腺功能减退史与痴呆诊断风险升高81%相关,其中需甲状腺激素替代治疗者风险增加超过3倍。

研究设计与样本

  • 全国性人群病例对照研究,使用台湾地区全民健康保险研究数据库,纳入2006至2013年新诊断痴呆且无痴呆或神经退行性疾病史的7843例成人,以及按年龄和性别匹配的7843例无痴呆对照。

主要发现

  • 共纳入15686例患者,病例组和对照组均以女性略多(4066例,51.8%)。
  • 痴呆组平均(SD)年龄为74.9(11.3)岁,无痴呆组为74.5(11.3)岁。
  • 65岁及以上人群中,有甲状腺功能减退史与痴呆诊断风险升高相关(aOR 1.81;95% CI 1.14-2.87;p=0.011)。
  • 50岁以上但65岁以下人群中未观察到该关联。
  • 65岁及以上有甲状腺功能减退史且接受甲状腺功能减退药物治疗者中,该关联最显著(aOR 3.17;95% CI 1.04-9.69;p=0.043)。

临床怎么用

  • 作者认为,未来应开展良好控制的前瞻性纵向研究以阐明这些潜在机制和关系。

局限性

  • 作者指出未来应开展良好控制的前瞻性纵向研究以阐明这些潜在机制和关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Dementia has been gaining attention in aging societies and is estimated to affect 50 million adults globally in 2020, and 12% of the US population may develop a thyroid disorder in their lifetime. There have been limited studies investigating the correlation between thyroid disorder and dementia in the Asian population. METHODS: Our large nationwide population-based case-control study used the Taiwanese National Health Insurance Research Database. A total of 7,843 adults with newly diagnosed dementia without a history of dementia or neurodegenerative disease between 2006 and 2013 were identified and included in our study. In addition, 7,843 adults without dementia diagnosis before the index date were age and sex-matched as controls. Diagnosis of hyperthyroidism or hypothyroidism before the diagnosis of dementia or the same index date was identified. Results were obtained from logistic regression models and adjusted for sex, age, history of hypertension, diabetes, coronary artery disease, depression, hyperlipidemia, alcohol dependence syndrome, tinnitus, hearing loss, and radioactive iodine treatment. RESULTS: A total of 15,686 patients were included in the study. Both case and control groups were slightly predominantly female (4,066 [51.8%]). The mean (SD) age for those with dementia was 74.9 (11.3) years and for those without dementia was 74.5 (11.3) years. Among patients aged 65 years or older, a history of hypothyroidism was associated with an increased risk of being diagnosed with dementia (adjusted odds ratio [aOR] 1.81; 95% CI 1.14-2.87; p = 0.011), which was an association not present in patients older than 50 years but younger than 65 years. We found that this association was most significant among patients aged 65 years or older with a history of hypothyroidism who received hypothyroidism medication (aOR 3.17; 95% CI 1.04-9.69; p = 0.043). DISCUSSION: Our large-scale case-control study found that among people aged 65 years or older, those with a history of hypothyroidism were associated with an 81% increased risk of having dementia and among those, there was a more than 3-fold increased dementia risk with thyroid conditions that required thyroid hormone replacement treatment. Future well-controlled prospective longitudinal studies should be conducted to elucidate these potential mechanisms and relationships. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that among patients aged 65 years or older, a history of hypothyroidism was associated with an increased risk of being diagnosed with dementia.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Wieland DR, Wieland JR, Wang H, et al. Thyroid Disorders and Dementia Risk: A Nationwide Population-Based Case-Control Study. Neurology. 2022. PMID: 35794019. doi:10.1212/WNL.0000000000200740

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。